.jpg)
The AcceleDent System is intended for 20 minutes of daily use. Patients bite down on the mouthpiece, which connects to an activator to deliver a light, pulsing force. The AcceleDent System also includes a travel shell and a charging port to recharge the device battery and provide compliance usage information that is captured by amicroprocessor in the activator.
While the AcceleDent System is currently sold in the United Kingdom and Australia, it is neither FDA-cleared nor FDA-approved, and is currently investigational only in the United States. OrthoAccel anticipates the conclusion of a US clinical trial at the UT Health Science Center in San Antonio later this year.
For more information about this and other orthodontic companies, visit our Buyer’s Guide.
 
					 
							 
			 
			 
			 
			 
			 
			